Odiparcil development advances with recruitment of first patients in a new biomarker study in MPS VI children and adults Study conducted in the United-States aims to consolidate leucocyte GAG and skin GAG content measurement as disease biomarkers in MPS VI children...
New peer-reviewed, published research finds that daily use of the dietary ingredient BioCell Collagen® can visibly reduce facial lines and crow’s feet wrinkles and boost skin elasticity IRVINE, California, Sept. 3, 2019 /PRNewswire/ — In one of the most...
At both standard and low budesonide doses, the triple-combination therapy showed a statistically-significant reduction in the rate of moderate or severe exacerbations compared with dual-combination therapies First time the benefit of two doses of a fixed...
Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, stock ticker: XYNO), a clinical stage US-China oncology drug development company, announced encouraging interim data from an ongoing Phase 1b study of its lead candidate abexinostat, an orally dosed, hydroxamic...
Surmodics has completed enrolment in TRANSCEND, its pivotal clinical trial for the SurVeil drug-coated balloon (DCB). “TRANSCEND is a rigorous level one, randomised controlled trial that comes at a very important time for the vascular and interventional community,”...
“The enrollment of the first patient in the United States is in line with our wish to make our product internationally available to patients suffering from dRTA” Tweet this Advicenne (Euronext Paris & Brussels: ADVIC – FR0013296746) (Paris:ADVIC)...
Email
Text